Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Key Points The growth hormone (GH)insulin-like growth factor (IGF) axis consists of central neuro-anatomical, regulatory and genetic systems, and the peripheral intracellular GH signalling pathway The introduction of recombinant human GH (rhGH) in 1985 ended the phase of pituitary-derived human growth hormone (hGH) and its associated limitations and risks, opening the possibility of widespread clinical use GH deficiency (GHD) is a syndrome with many different causes and is associated with alterations in growth, body composition and metabolism In some non-GHD short stature disorders, rhGH has been proved effective and is used as a surrogate for the currently unknown, pathophysiologically appropriate treatment Risks of hGH therapy might relate to its direct effects on growth, its anti-insulin action and its cell-proliferating activity
Am J Physiol Cell Physiol 287(4):C817C833
|Minocycline is known for its excellent tissue penetration and long duration of action
If you are pregnant or nursing, consult with your healthcare provider
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: A post hoc analysis of the randomised ATTEMPT study
US$ 23.76
US$ 28.61
US$ 21.89
US$ 27.43
.jpg)
